Does HRT Increase Dementia Risk? New 1M Woman Study

For years, many Canadian women felt that the topic of menopause, not to mention Hormone Replacement Therapy (HRT) was a “no-go” zone. If you’ve ever felt like you were just expected to “tough it out” through menopause, you aren’t alone.

But today, the tide is turning. We are finally entering an era where HRT and other menopause care is becoming more accessible for relief of menopause symptoms in Canada. And a massive new study is giving women even more reason to feel confident about their brain health if they choose to take Menopause Hormone Therapy.

Does estrogen protect the brain, or does it accelerate decline? According to a definitive new study published in The Lancet Healthy Longevity, the answer appears to be neither.

The comprehensive study concludes that there is no evidence to suggest that HRT either increases or decreases the risk of dementia in post-menopausal women. While the findings provide a sense of “neutral” clarity for women managing menopausal symptoms, they also shine a spotlight on a frustrating reality: we still don’t fully understand why women are disproportionately affected by Alzheimer’s disease.

The Power of Numbers: 1 Million Participants

This wasn’t a small-scale study. Researchers conducted a systematic review and meta-analysis of 10 previous studies, encompassing data from more than one million participants.

By pooling this massive dataset, researchers were able to look past the “noise” of smaller, conflicting studies. Whether women used estrogen-only therapy or combined HRT (estrogen and progestogen), the results remained consistent: there was no significant statistical link to dementia risk.

For women currently using HRT to manage debilitating symptoms like hot flashes, night sweats, or bone density loss, this study offers a significant “green light” regarding safety. It suggests that while HRT shouldn’t be prescribed specifically as a tool to prevent dementia, it also shouldn’t be feared as a cause of it.

The “Estrogen Gap” and the Alzheimer’s Mystery

Despite these reassuring findings regarding HRT, a significant question mark remains over women’s health. It is a well-documented but poorly understood fact that women make up nearly two-thirds of all Alzheimer’s cases.

For a long time, the medical community dismissed this disparity by simply stating that “women live longer.” However, experts like Dr. Natasha Rajah, a prominent neuroscientist, argue that longevity is only a small piece of the puzzle. In a recent interview with The Health Insider, Dr. Rajah emphasized that biological transitions, specifically menopause, play a critical role in brain aging.

“Women’s brains undergo a significant transition during midlife that men’s brains simply don’t experience,” Dr. Rajah noted. The “estrogen hypothesis” suggests that the sharp decline in hormones during menopause may trigger changes in the brain’s metabolic system, potentially making it more vulnerable to the plaques and tangles associated with Alzheimer’s.

Why More Research is Non-Negotiable

The Lancet study is a milestone in closing the book on the HRT-dementia debate, but it also serves as a call to action. If HRT is neutral, then the “why” behind the female Alzheimer’s epidemic lies elsewhere, and we aren’t looking hard enough to find it.

Historically, clinical trials have often been “male-centric,” failing to account for the unique fluctuations of the female endocrine system. Dr. Rajah and other advocates argue that we need to move beyond general studies and dive into:

• The Menopause Transition: How the perimenopause-to-postmenopausal window affects neurological “resilience.”
• Genetic Interactions: Why the APOE4 gene—the strongest genetic risk factor for Alzheimer’s—seems to impact women’s brains more severely than men’s.
• Lifestyle and Environment: How metabolic health, socioeconomic factors, education, career, and stress levels interact with female biology over a lifetime.

The latest research provides peace of mind for women navigating menopause: HRT is increasingly recognized as a safe tool for many women for menopause symptom management. With the new study concluding that it does not appear to jeopardize long-term cognitive health, women in need can feel a bit safer when prescribed HRT.

Subscribe to The Health Insider to stay up to date on breakthroughs in menopause care in Canada.

~ Read more from The Health Insider ~

• 
  Does HRT Increase Dementia Risk? New 1M Woman Study2026-01-20
  A study of 1M women finds HRT doesn’t increase dementia risk. We dive into the findings and why women are still more likely to face Alzheimer’s.
• 
  The Best Food for Bone Health? It’s Probably Not What You Think2025-10-30
  Forget milk — science says this humble dried fruit could help slow bone loss.
• 
  Empower and Inform Your Menopause Journey: Expert Interview with Amanda Thebe2025-10-23
  Author, nutritionist, and women’s health advocate Amanda Thebe shares insights on hormone therapy, nutrition, strength training, and lifestyle strategies — showing why understanding your body is the most powerful tool for thriving through midlife.
• 
  The New Era of Menopause Care: What’s Changing for Canadian Women2025-10-16
  In this interview, Dr. Amy Louis Bayliss reveals how menopause is an opportunity to take charge of your health and shares her decade by decade action plan. Dr. Amy also shares how new Ontario standards will ensure more doctors discuss menopause care proactively.
• 
  Why Alzheimer’s Hits Women Harder: A Q+A with Dr. Natasha Rajah2025-09-30
  Women make up the majority of Alzheimer’s patients. Dr. Rajah breaks down the science behind this gender gap and what it means for treatment.
• 
  Vitamin K2: Your Ally to Combat Bone Loss2025-08-20
  From bone density to heart health, vitamin K2 plays a powerful role. See why the MK-7 form of the vitamin leads the way.

The information provided on TheHealthInsider.ca is for educational purposes only and does not substitute for professional medical advice. TheHealthInsider.ca advises consulting a medical professional or healthcare provider when seeking medical advice, diagnoses, or treatment. To read about our editorial review process click here.